Please use this identifier to cite or link to this item: http://repositorio.unifesp.br/handle/11600/37754
Title: Randomized, proof-of-principle clinical trial of active transcranial magnetic stimulation in chronic migraine
Authors: Conforto, Adriana B.
Amaro, Edson
Goncalves, Andre L.
Mercante, Juliane P. P.
Guendler, Vera Z.
Ferreira, Josione R.
Kirschner, Clara C. F. B.
Peres, Mario F. P. [UNIFESP]
Hosp Israelita Albert Einstein
Universidade de São Paulo (USP)
Universidade Federal de São Paulo (UNIFESP)
Keywords: Placebo
dorsolateral prefrontal cortex
transcranial magnetic stimulation
chronic migraine
pain
Issue Date: 1-May-2014
Publisher: Sage Publications Ltd
Citation: Cephalalgia. London: Sage Publications Ltd, v. 34, n. 6, p. 464-472, 2014.
Abstract: Background High-frequency repetitive transcranial magnetic stimulation of the left dorsolateral prefrontal cortex (rTMS-DLPFC) is an effective treatment for depression. Preliminary studies indicated beneficial effects of rTMS-DLPFC on pain relief in patients treated for depression, and in patients with chronic migraine.Methods in this randomized, double-blind, parallel-group, single-center, proof-of-principle clinical trial, we tested the hypothesis that 23 sessions of active rTMS-DLPFC delivered over eight weeks would be feasible, safe and superior to sham rTMS to decrease the number of headache days in 18 patients with chronic migraine without severe depression. Per-protocol analysis was performed.Results rTMS-DLPFC applied over eight weeks was feasible and safe in patients with chronic migraine. Contrary to our primary hypothesis, the number of headache days decreased significantly more in the sham group than in the group treated with active rTMS-DLPFC at eight weeks. Average decrease in headache days was >50% in the sham group, indicating a powerful placebo response. Pain intensity improved in both groups to a similar extent.Conclusions Positive results of M1 stimulation in other studies, and the absence of significant benefits of active high-frequency rTMS of the DLPFC in the present study, point to M1 as a more promising target than the DLPFC, for larger trials of noninvasive brain stimulation in patients with chronic migraine.
URI: http://repositorio.unifesp.br/handle/11600/37754
ISSN: 0333-1024
Other Identifiers: http://dx.doi.org/10.1177/0333102413515340
Appears in Collections:Em verificação - Geral

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.